Total Payments
$461,190
2024 Payments
$40,386
Companies
70
Transactions
1,143
Medicare Patients
4,188
Medicare Billing
$442,972
Payment Breakdown by Category
Other$327,125 (70.9%)
Consulting$84,021 (18.2%)
Food & Beverage$30,179 (6.5%)
Travel$19,704 (4.3%)
Education$161.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $325,745 | 258 | 70.6% |
| Consulting Fee | $84,021 | 13 | 18.2% |
| Food and Beverage | $30,179 | 807 | 6.5% |
| Travel and Lodging | $19,704 | 56 | 4.3% |
| Honoraria | $1,380 | 1 | 0.3% |
| Education | $161.24 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $148,982 | 217 | $0 (2024) |
| Lilly USA, LLC | $111,441 | 141 | $0 (2024) |
| PREVENTRIC DIAGNOSTICS, INC. | $78,083 | 6 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $61,182 | 110 | $0 (2024) |
| Amgen Inc. | $39,643 | 92 | $0 (2024) |
| Abbott Laboratories | $7,075 | 91 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $2,101 | 69 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,110 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $871.75 | 41 | $0 (2024) |
| Boston Scientific Corporation | $830.87 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,386 | 120 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,686) |
| 2023 | $46,248 | 167 | Lilly USA, LLC ($24,567) |
| 2022 | $55,958 | 136 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31,189) |
| 2021 | $161,413 | 207 | PREVENTRIC DIAGNOSTICS, INC. ($78,083) |
| 2020 | $42,590 | 136 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,419) |
| 2019 | $44,172 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,440) |
| 2018 | $48,198 | 151 | Amgen Inc. ($19,305) |
| 2017 | $22,226 | 82 | Amgen Inc. ($19,743) |
All Payment Transactions
1,143 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $132.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $93.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $132.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Acarix USA Inc. | CADScor System (Device) | Food and Beverage | In-kind items and services | $146.78 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $100.92 | General |
| 11/12/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiovascular Diseases | ||||||
| 10/25/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $37.34 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/23/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Education | In-kind items and services | $70.41 | General |
| Category: Hypertension | ||||||
| 10/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.88 | General |
| 10/11/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Biological | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $39.80 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.39 | General |
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 929 | 1,301 | $289,616 | $94,001 |
| 2022 | 14 | 1,101 | 1,420 | $356,900 | $112,082 |
| 2021 | 15 | 1,142 | 1,488 | $365,608 | $111,048 |
| 2020 | 15 | 1,016 | 1,737 | $426,967 | $125,842 |
Total Patients
4,188
Total Services
5,946
Medicare Billing
$442,972
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 441 | $77,175 | $40,909 | 53.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 127 | 135 | $81,000 | $20,310 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 119 | $15,875 | $8,546 | 53.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $13,500 | $6,385 | 47.3% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 64 | 64 | $12,800 | $4,440 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 198 | 285 | $17,955 | $3,053 | 17.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 28 | 42 | $5,250 | $2,911 | 55.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 29 | $18,371 | $2,215 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $14,357 | $1,657 | 11.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 24 | $6,600 | $1,259 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 14 | 14 | $9,703 | $821.55 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 16 | $9,280 | $813.92 | 8.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 62 | 62 | $7,750 | $680.15 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 333 | $58,700 | $30,217 | 51.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 131 | 136 | $81,600 | $21,422 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 225 | $28,125 | $15,369 | 54.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 20 | 20 | $30,000 | $14,811 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $14,000 | $7,111 | 50.8% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2022 | 83 | 83 | $16,600 | $5,583 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 69 | 73 | $42,340 | $3,883 | 9.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 51 | 51 | $35,346 | $3,355 | 9.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 205 | 284 | $17,904 | $3,012 | 16.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 17 | 17 | $5,950 | $2,645 | 44.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 13 | 13 | $5,200 | $2,000 | 38.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 84 | 84 | $10,500 | $929.41 | 8.9% |
About Dr. Asif Ali, MD
Dr. Asif Ali, MD is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881621993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asif Ali, MD has received a total of $461,190 in payments from pharmaceutical and medical device companies, with $40,386 received in 2024. These payments were reported across 1,143 transactions from 70 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($325,745).
As a Medicare-enrolled provider, Ali has provided services to 4,188 Medicare beneficiaries, totaling 5,946 services with total Medicare billing of $442,972. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Houston, TX
- Active Since 06/26/2006
- Last Updated 02/16/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881621993
Products in Payments
- JARDIANCE (Drug) $258,547
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $78,083
- LifeVest (Device) $61,182
- Repatha (Biological) $39,539
- Confirm Rx (Device) $1,537
- Bidil (Drug) $1,432
- Merlin Connectivity and Remote (Device) $1,288
- XARELTO (Drug) $871.75
- ELIQUIS (Drug) $660.82
- LEQVIO (Drug) $649.48
- OCTRODE (Device) $497.56
- Impella (Device) $483.15
- Resolute (Device) $479.91
- CONFIRM RX (Device) $471.88
- ENTRESTO (Drug) $443.88
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $341.66
- Carnation Ambulatory Monitor (Device) $334.93
- Edarbyclor (Drug) $327.45
- CARDIOMEMS (Device) $311.90
- Cleerly Labs (Device) $288.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547
Arvind Bhimaraj, M.d.,, M.D.,
Cardiovascular Disease — Payments: $238,280
Cardiovascular Disease $238,280